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Abstract
The effects of in vitro and in vivo treatment of bovine polymorphonuclear leukocytes with recombinant
bovine interferon-γ on in vitro bovine polymorphonuclear leukocyte functions and the survival of Brucella
abortus were determined. Activation of neutrophils in vitro with interferon-γ resulted in enhanced production
of O2− and myelopeoroxidase-H2O2-halide activity by neutrophils in the presence of B. abortus. The
improved iodination responses were correlated with an enhanced ability to perform iodination in the presence
of 5′-guanosine monophosphate and adenine which have previously been shown to contribute to inhibition of
neutrophil myeloperoxidase-H2O2-halide activity by B. abortus. The ability of opsonized B. abortus to survive
in the presence of neutrophils activated in vitro or in vivo was partially decreased by ∼10% of control when
compared to survival rates within control phagocytes. These results suggest that activation of neutrophils with
recombinant interferon-γ partially enhances their oxidative metabolic responses, resulting in a slightly
enhanced ability to kill virulent B. abortus.
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ABSTRACT 
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Canning, P.C. and Roth, J.A., 1989. Effects of in vitro and in vivo administration of recombinant 
bovine interferon-yon bovine neutrophil responses to Brucella abortus. Vet. Immunol. Immu-
nopathol., 20: 119-133. 
The effects of in vitro and in vivo treatment of bovine polymorphonuclear leukocytes with 
recombinant bovine interferon-yon in vitro bovine polymorphonuclear leukocyte functions and 
the survival of Brucella abortus were determined. Activation of neutrophils in vitro with inter-
feron-y resulted in enhanced production of 0 2 - and myelopeoroxidase-H20 2-halide activity by 
neutrophils in the presence of B. abortus. The improved iodination responses were correlated with 
an enhanced ability to perform iodination in the presence of 5' -guanosine monophosphate and 
adenine which have previously been shown to contribute to inhibition of neutrophil myeloperox-
idase-H20 2-halide activity by B. abortus. The ability of opsonized B. abortus to survive in the 
presence of neutrophils activated in vitro or in vivo was partially decreased by ~ 10% of control 
when compared to survival rates within control phagocytes. These results suggest that activation 
of neutrophils with recombinant interferon-y partially enhances their oxidative metabolic re-
sponses, resulting in a slightly enhanced ability to kill virulent B. abortus. 
INTRODUCTION 
Brucella abortus, the etiologic agent of brucellosis, is a facultative intracell-
ular bacterium capable of surviving within phagocytic cells. The mechanisms 
used by the organism to survive within polymorphonuclear leukocytes ( PMN s) 
are not fully understood. Previous studies have indicated that both smooth and 
rough strains of B. abortus are efficiently ingested by bovine and human neu-
trophils (Robertson et al., 1979; Riley and Robertson). This work also indi-
cated that the products ofthe myeloperoxidase-H20 2-halide (MPO-H20 2-hal-
0165-2427/89/$03.50 © 1989 Elsevier Science Publishers B.V. 
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ide) antibacterial system of the neutrophil are capable of killing B. abortus. 
Other studies (Morris, 1977; Kreutzer et al., 1979) indicate that ingestion of 
non-opsonized B. abortus and organisms treated with heat-inactivated homol-
ogous normal bovine serum does not stimulate a respiratory burst by PMNs. 
Recent experiments (Harmon and Adams, 1987) have indicated that opson-
ized B. abortus are capable of eliciting an oxidative response by bovine mam-
mary gland macrophages. Similar experiments involving bovine neutrophils 
have confirmed that ingestion of B. abortus opsonized with specific antibody 
stimulates 0 2 - production by bovine PMNs (Canning et al., 1988). Thus, a 
lack of stimulation of a respiratory burst by neutrophils upon ingestion of the 
bacteria does not appear to contribute to the intracellular survival of antibody-
opsonized B. abortus. 
Virulent B. abortus possess two components (fractions 3b and 10) which 
inhibit the (MPO-H20 2-halide) antibacterial reaction of PMNs (Canning et 
al., 1985). Further studies have indicated that specific suppression of primary 
granule degranulation by the bacteria is responsible for the decreased MPO-
H202-halide activity of the phagocytes (Bertram et al., 1986). Fraction 3b has 
been identified as GMP and fraction 10 as adenine (Canning et al., 1986). 
These results were in agreement with those of other workers (Chiang et al., 
1986) which indicated purine nucleotides, nucleosides and bases were capable 
of suppressing iodination responses of bovine PMN s. 
Previous studies indicate that protection against a variety of facultative in-
tracellular bacteria including B. abortus is primarily dependent upon cell-me-
diated immune responses (Campbell, 1976; Cheers and Pagram, 1979). Nu-
merous lymphocyte-derived products have been shown to modulate the 
responses of the cellular immune system to infection. Considerable amounts 
of data have accumulated which detail the immunoregulatory activities of in-
terferon-y(IFN-y). In vitro activities attributed to this lymphokine include 
induction of major histocompatibility antigens on cell surfaces (Wallach et al., 
1982; Basham and Merigan, 1983), activation of macrophage-mediated cyto-
toxicity (Pace et al., 1985), and activation of oxidative and microbicidal activ-
ities of peritoneal and alveolar macrophages (Nathan et al., 1983; McCabe et 
al., 1984; Hoover et al., 1985; Murray et al., 1985). In vivo administration of 
recombinant IFN-y enhances the anti-toxoplasma activity of murine perito-
neal macrophages (Black et al., 1987). Both respiratory burst and lysosomal 
enzyme release activities of human neutrophils were shown to be enhanced in 
the presence of purified human IFN-y (Kowanko and Ferrante, 1987). It has 
been shown (Steinbeck et al., 1986) that bovine PMNs exposed to recombi-
nant bovine IFN -y exhibited suppressed random migration under agarose while 
their ability to ingest Staphylococcus aureus, produce superoxide anion and 
perform myeloperoxidase-mediated iodination was not affected. Both anti-
body -dependent cell-mediated cytotoxicity ( ADCC) and antibody-indepen-
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dent neutrophil cytotoxicity(AINC) activities were enhanced in the presence 
ofiFN-y. 
The purpose of the present study was to determine the effects of in vitro and 
in vivo activation of PMNs with IFN-y on the interactions of bovine PMNs 
with B. abortus. 
MATERIALS AND METHODS 
Preparation of bacteria 
The procedures used to grow B. abortus have been described in detail previ-
ously (Canning et al., 1985). Smooth virulent strain 2308 of B. abortus was 
grown on potato agar slants (Difco, Detroit, MI). Following incubation for 48 
hat 37 a C, the cells were harvested and washed three times with saline ( 0.85% 
NaCl). Following washing, the bacteria were resuspended in Earle's balanced 
salt solution (EBSS, Grand Island Biologics Co., Grand Island, NY) at a con-
centration of either 1 X 1010 or 1 X 107 cells/ml. 
Nucleotide and base preparations 
Authentic samples of GMP and adenine were purchased from Sigma Chem-
ical Co., St. Louis, MO. For the PMN function assays, a solution containing 
0.1 mg/ml each of GMP and adenine was prepared in EBSS. 
In vitro and in vivo activation of PMNs 
Eight apparently healthy adult Holstein-Friesian cows free of detectable anti-
Brucella antibodies were used as a source of neutrophils for the in vitro acti-
vation studies. Bovine PMNs were isolated as previously described (Roth and 
Kaeberle, 1981) and resuspended in RPMI 1640 (Grand Island Biologic Co., 
Grand Island, NY). In vitro activation of neutrophils with IFN -y was per-
formed using procedures described previously (Steinbeck et al., 1986). Recom-
binant bovine IFN-y containing< 10ng/ml of endotoxin was obtained from 
Ciba-Geigy Limited, Basel, Switzerland (Lot no. 3229/38). A solution con-
taining 2X 10- 8 g/ml ofiFN-ywas prepared in RPMI 1640. This material used 
at a final concentration of 1 X 10-8 g/ml (22 U /ml) has been shown to provide 
maximal activation of bovine neutrophils (Steinbeck et al., 1986). Standard-
ized PMNs (1 X 108 cells/ml for migration, cytochrome c reduction, or iodi-
nation assays or 2 X 107 cells/ml for bactericidal assays) were mixed with an 
equal volume of IFN -y solution and the cells were incubated for 2 h at 37 o C in 
a humidified atmosphere containing 5% C02• Control preparations of neutro-
phils were incubated with an equal volume of RPMI 1640. Both treated and 
control PMNs were then used in the functional assays without washing. 
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Fifteen apparently healthy adult Holstein-Friesian and Brown Swiss steers 
were randomly divided into two treatment groups and one control group each 
containing five animals for use in the in vivo activation studies. There were no 
differences in in vitro neutrophil function parameters between groups prior to 
the initiation of the experiment. The stock solution of IFN -y was diluted in 
phosphate-buffered saline solution (PBS, 0.15 M, pH 7.2) prior to use. Ani-
mals in each treatment group were given a single subcutaneous injection of 5.0 
ml of PBS containing 0.0, 0.1, or 0.5 mg (0, 2.2X105 , or 1.1X106 Units) of 
recombinant IFN-y. Bovine PMNs were isolated, as referenced above, 24, 48, 
and 72 h after treatment. The cells were resuspended in PBS at a concentration 
of either 5 X 107 cells/ml for migration and iodination assays or 1 X 107 cells/ 
ml for bactericidal assays. 
PMN function assays 
Random migration under agarose 
This assay was used to determine if PMN s exposed to IFN -y were activated 
by the treatment as evidenced by a decrease in migration ability. Agar used in 
the assay consisted of RPMI 1640 containing 1.0% agarose (Bethesda Re-
search Laboratories, Bethesda, MD), 10% fetal bovine serum, and 0.1% gen-
tamycin sulfate (Schering Corp., Kenilworth, NJ). Eight ml of warm agar 
( 48 o C) was added to graduated radial immunodiffusion plates (Miles Labo-
ratories, Elkhart, IN) and the plates were stored at 4 o C prior to use. To eval-
uate random migration, 12.0 .ul of either control or IFN-y-activated PMNs 
were added to wells ( 3.0 mm in diameter) in the agar. The migration plates 
were incubated for 5 h in a humidified 5% C02 atmosphere at 37 o C. Following 
incubation, the agar surface was flooded with an 8% solution of glutaraldehyde 
for an additional30 min to fix the PMNs to the plate. The agar was removed 
and the cells adhering to the plate were stained with modified Wrights stain 
(Diff-Quick, Harleco, Gibbstown, NJ). The area of migration was determined 
by direct observation using an inverted tissue culture microscope and the area 
of the center well was corrected for by subtraction. The results were expressed 
as the mean percent of control. 
Cytochrome c reduction 
This test was used to determine the amount of 0 2 - produced by control and 
in vitro-activated PMNs during the oxidative metabolic burst. The assay was 
performed in 96-well plates with membrane filters attached to the bottom of 
the wells (Millititer™ Model SV, 0.45 .urn pore size, Millipore Co., Bedford, 
MA) as previously described (Canning et al., 1986). Samples were evaluated 
in duplicate and the average of duplicate values was used for calculation. The 
filters of the wells were prewetted with a solution of 0.5% bovine serum albu-
min prior to the addition of reaction reagents. The standard reaction mixture 
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contained 0.075 ml of cytochrome c solution (stock solution=538 11M in 
EBSS), 0.025 ml of PMN s in PBS ( 1.25 X 206 PMN s), 0.05 ml of EBSS, and 
0.025 ml ofpreopsonized zymosan (7.5 mg/ml in EBSS ). Measurement of02 -
production by resting PMNs was performed similarly, except the preopsonized 
zymosan was replaced with 0.025 ml of EBSS. To determine the effects of B. 
abortus on production of 0 2 - by opsonized zymosan-stimulated PMNs, 0.05 
ml of B. abortus (5 X 108 bacteria/well) was substituted for the EBSS in the 
reaction mixture. The ability of superoxide dismutase to inhibit the reduction 
of cytochrome c by opsonized zymosan-stimulated PMNs was evaluated by 
adding 0.01 ml of superoxide dismutase (0.1 mg/ml) to the reaction mixture. 
Control and principal wells contained the same final volume of fluid. The re-
action was started with the addition of either control or IFN-y-activated PMNs. 
Following incubation at 37oC for 30 min with agitation, the culture filtrates 
were collected into a conventional96-well flat-bottomed plate. The entrapped 
PMNs were washed twice by filtration with 0.075 ml of EBSS which was also 
collected. The plates were agitated briefly, and the optical density of the solu-
tions at 550 nm was determined using a micro ELISA spectrophotometer 
(Model MR 600, Dynatech Corp., Alexandria, VA). The nmoles of 0 2 - pro-
duced by 106 PMNs in 30 min were determined using the extinction coefficient 
of2.1Xl04 cm- 1 M- 1• 
Iodination assay 
The iodination assay (a measure of MPO-H20 2-halide activity by PMNs) 
was performed as previously described (Roth and Kaeberle, 1981) in 12 X 75 
mm tubes in duplicate and the average of duplicate values was used for calcu-
lations. The standard reaction mixture contained 0.05 ml of PMNs (2.5 X 106 
cells), 0.1 11Ci of [l 25I] in 0.025 ml of EBSS (carrier free, Amersham Corp., 
Arlington Heights, IL), 0.05 ml of Nai in EBSS (20 nmoles), and 0.3 ml of 
EBSS. Various concentrations of opsonized zymosan (0.05 ml) were used to 
stimulate iodination activity by control or activated PMNs. Iodination by rest-
ing cells was determined similarly, except preopsonized zymosan was omitted 
from the reaction mixture. To determine the effects of the GMP and adenine 
mixture or B. abortus on the MPO-H20 2- halide activity of opsonized zymosan-
stimulated PMNs, 0.05 ml of the purine mixture, or 0.05 ml of the bacterial 
suspension ( 5 X 108 bacteria/tube), or 0.05 ml of EBSS as a control was added 
to the standard reaction mixture. Following preincubation of the tubes at 37 o C 
for 10 min, the reaction was started with the addition of either control or IFN-
y-activated PMNs. The tubes were incubated for 20 min at 37°C with tumbling 
before the amount of trichloroacetic acid-precipitable radioactivity was deter-
mined. The results were expressed as nmoles of Nai/107 PMNs h - 1• 
Bacterial killing assay 
This assay was used to measure the total number of bacteria killed by an 
aliquot of control or IFN -y-activated PMN s over a period of time. The test was 
124 
performed in 96-well microtiter plates. Fifty ,ul of B. abortus ( 1 X 107 cells/ml) 
were opsonized with 25 ,ul of a subagglutinating dilution of bovine anti-B. abor-
tus sera. Following incubation for 10 min at 37 o C, 50 ,ul ( 1 X 107 cells/ml) of 
either control or IFN-y-activated PMNs were added to each well resulting in a 
1:1 ratio ofbacteria:PMNs. This ratio of bacteria to PMNs was chosen to in-
sure that the majority of the bacteria were ingested by the phagocytes. Control 
wells contained either bacteria mixed with sera and RPMI-1640 or bacteria 
mixed with sera and RPMI 1640 containing 1 X 10-8 g/ml ofiFN-y. Control 
and principal wells contained the same volume of fluid. The reaction mixtures 
were incubated at 37 o C with agitation and 5-,ul aliquots were removed at 0, 30, 
60, and 120 min intervals for the in vitro studies or 30 and 90 min intervals for 
the in vivo studies. The aliquots were diluted in 0.15 M phosphate-buffered 
deionized water (pH 7.2) to lyse the PMNs and 100 ,ul of each dilution was 
plated on duplicate tryptose agar plates. Following incubation for 72 h, plates 
containing between 30 and 300 colonies were examined to determine the num-
ber ofCFU. 
Statistical analysis 
To determine the effects of different bacterial preparations or the purine 
mixture on each PMN function, the mean values obtained when a bacterial 
preparation or purine mixture was added to PMNs was compared with the 
mean values for control (EBSS-treated) PMNs from the same animal. The 
effects of in vitro recombinant IFN -y treatment on PMN function were deter-
mined by comparing the mean values obtained when PMNs were treated with 
IFN-y with the mean values for control (RPMI 1640) PMNs from the same 
animal. Similarly, the effects of in vivo recombinant IFN -y treatment on PMN 
function were determined by comparing the mean value obtained with PMNs 
from IFN-y-treated animals with the mean value for PMNs from control ani-
mals. Either an analysis of variance procedure (blocked by day) or a Student's 
t-test were used to determine significance of the differences in PMN function. 
RESULTS 
Effects of in vitro activation of PMNs with IFN-y 
Random migration 
Exposure of PMN s to IFN -y for 2 h had no detrimental effect on the viability 
of the phagocytes (mean viability post treatment was 97%). In vitro activation 
of PMNs with recombinant bovine IFN -y significantly (P < 0.01) suppressed 
the ability of neutrophils to migrate under agarose to 41.8 :±: 4.8% of control. 
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Superoxide anion production 
Results of the 0 2 - production studies are shown in Fig. 1. Significant 
(P< 0.01) production of02- by neutrophils was stimulated by opsonized zym-
osan, and the mixture of B. abortus with opsonized zymosan. Opsonized zym-
osan -stimulated production of 0 2 - by PMN s was not significantly (P < 0.05) 
affected in the presence of B. abortus. The ability of opsonized zymosan-stim-
ulated PMNs to reduce cytochrome c was suppressed by > 95% in the presence 
of superoxide dismutase. 
The ability of both resting and opsonized zymosan-stimulated PMNs to pro-
duce 0 2 - was enhanced in the presence of IFN -y. The (mean± SEM) value 
for 0 2 - production by resting PMNs increased from 1.9 ± 0.3 nmol 0 2 -/106 
PMNs per 30 min to 2.9 ± 0.3 nmol 0 2 -/106 PMNs per 30 min. Opsonized 
zymosan -stimulated production of 0 2 - increased from 13.0 ± 0.9 nmol 0 2 -; 
106 PMNs per 30 min to 17.4± 1.0 nmol 0 2 -/106 PMNs per 30 min. A similar 
enhancement of opsonized zymosan -stimulated production of 0 2 - in the pres-
ence of B. abortus was observed with IFN -y pretreatment of PMN s. 
Iodination 
Results of the iodination assays designed to determine the optimum concen-
tration of opsonized zymosan to use for stimulation of control and in vitro-
activated PMNs are shown in Fig. 2. The concentration of opsonized zymosan 
which provided the greatest sensitivity for the detection of either enhancement 
or suppression of iodination activity was approximately 8.0 mg/ml (0.4 mg/ 
tube). This concentration of opsonized zymosan was used for all subsequent 
experimentation. 
Results of the iodination assays involving RPMI -1640-treated and in vitro-
activated PMNs are shown in Fig. 3. Significant (P<0.01) increases in iodi-
nation activity occurred when PMNs were stimulated with opsonized zymosan 
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Fig. 1. Superoxide anion production by control and IFN-y-treated PMNs (mean± SEM, n=6). 
Asterisks denote a statistically different response between IFN-y-treated and control cells. 
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Fig. 3. Iodination responses of control and IFN -y-treated PMNs (mean± SEM, n = 6). Asterisks 
denote a statistically different response between IFN-y-treated and control cells. 
(27.4±1.8 nmol Nal/107 PMNs h- 1 ). Opsonized zymosan-stimulated iodi-
nation was significantly (P< 0.01) suppressed to 10.3 ± 0.9 nmoles Nal/107 
PMNs h- 1 and 21.6±2.6 nmoles Nal/107 PMNs h- 1 in the presence ofGMP 
and adenine or live B. abortus respectively. 
Pretreatment of PMNs with IFN-y for 2.0 h significantly (P< 0.01) in-
creased the ability of opsonized zymosan-stimulated neutrophils to iodinate 
proteins when compared to RPMI-1640-treated cells (35.9 ± 2.9 nmoles Nal/ 
107 PMNs h- 1 vs. 27.4 ± 1.8 nmol Nal/107 PMNs h- 1 respectively). The abil-
ity of PMNs to perform opsonized zymosan-stimulated iodination in the pres-
ence of GMP and adenine was also significantly (P<O.Ol) increased from 
10.3±0.9 nmol Nal/107 PMNs h- 1 to 15.1±0.5 nmol Nal/107 PMNs h- 1 by 
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IFN-y pretreatment of PMNs. Similarly, opsonized zymosan-stimulated iodi-
nation in the presence of B. abortus was increased from 21.6 ::t 2.6 nmol Nal/ 
107 PMNs h- 1 to 28.7::!:2.8 nmol Nal/107 PMNs h- 1 by IFN-ypretreatment 
ofPMNs. 
Bactericidal activity 
Results of the studies to determine the effects of in vitro administration of 
IFN-y on the brucellacidal activity of PMNs are shown in Fig. 4. Exposure of 
B. abortus to immune sera for up to 2 h did not affect the survival of the bacteria 
(data not shown). Treatment of B. abortus with IFN -y alone had no effect on 
the viability of the bacteria. Pretreatment ofPMNs with IFN-yfor 2 h resulted 
in a slightly increased ability of neutrophils to kill B. abortus. Approximately 
0.4 7::!: 0.04 log10 of the bacteria were killed following 2 h of incubation with 
normal PMNs. Neutrophils activated with IFN-y were capable of killing 
0.64::!: 0.05 log10 of exposed B. abortus, a statistically significant (P < 0.01) 
greater number than normal PMNs. The greatest difference in killing poten-
tial between normal and IFN-y-treated PMNs occurred within the first 30 min 
following the addition of bacteria. Normal PMNs killed 0.12::!: 0.02log10 of B. 
abortus during the first 30 min of exposure, while IFN -y-treated PMNs killed 
0.28::t0.03log10 of the organisms in the same amount oftime. 
Effects of in vivo activation of PMNs with IFN-y 
Random migration 
In vivo treatment of animals with recombinant bovine IFN -y suppressed the 
ability of neutrophils to migrate under agarose in a dose- and time-dependent 
manner when compared with PMNs from non-treated animals. Treatment of 
animals with 0.5 mg of IFN -y significantly (P < 0.01) inhibited the ability of 
PMNs to migrate to 43.1::!: 10.0% of control24 h following the administration 
of IFN-y. The inhibition of migration was no longer detectable at either 48 or 
72 h post-treatment. Neutrophils from animals treated with 0.1 mg of IFN-y 
did not exhibit any significant (P> 0.05) reduction in migration capability at 
any of the times evaluated. 
Iodination 
Results of the iodination assays involving PMNs from normal and IFN-y-
treated animals are shown in Fig. 5. Neutrophils from control animals had a 
mean ( :±: SEM) iodination value of 24.9::!:3.6 nmol Nal/107 PMNs h- 1 when 
stimulated with opsonized zymosan. Opsonized zymosan-stimulated iodina-
tion by PMNs from control animals was significantly (P<0.05) suppressed in 
the presence of GMP and adenine or live B. abortus to 16.4 :±: 2.3 and 16.4 :±: 2.0 
nmol Nal/107 PMNs h- 1 respectively. 
Interferon-y treatment of animals significantly (P<O.Ol) enhanced the io-
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dination activity of EBSS-treated PMNs in a dose- and time-dependent man-
ner. The ability of PMNs from animals given either the low or high dose of 
IFN -y to perform opsonized zymosan -stimulated iodination in the presence of 
G MP and adenine was significantly (P < 0.01) increased from 16.4 ± 2.3 nmol 
Nal/107 PMNs h- 1 to 22.3±1.0 or 31.3±3.9 nmol Nal/107 PMNs h- 1 re-
spectively 24 h after IFN-y treatment. Both the low and high doses of IFN-y 
enhanced opsonized zymosan-stimulated iodination in the presence of B. abor-
tus from 16.4±2.0 nmol Nal/107 PMNs h- 1 to 20.7±1.8 or 27.0±2.1 nmol 
Nal/107 PMNs h- 1 respectively within 24 h of IFN-y treatment. However, 
both the purine mixture and B. abortus were still capable of inhibiting iodi-
nation by the IFN-y activated PMNs. Neither dose of IFN-y resulted in en-
hanced iodination activity at 48 or 72 h post-treatment. 
Bactericidal activity 
Results of the bactericidal assays involving PMNs from normal and IFN-y-
treated animals (Fig. 6) were similar to those for the vitro activation studies. 
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Fig. 6. Bactericidal activity of PMNs from IFN-y-treated and control animals (mean±SEM, 
n = 5) for B. abortus during a 90-min incubation period. Graphs A, B, and C represent 24, 48, and 
72 h post-treatment respectively. Asterisks denote a statistically different response from PMNs 
obtained from control animals. 
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Opsonized bacteria incubated with PMN s from control animals were killed in 
a time-dependent manner with approximately 5.07::!::: 0.04 log10 of the orga-
nisms surviving after 30 min of exposure and 4.94::!::: 0.08 log10 of the bacteria 
surviving at 90 min. 
Treatment of animals with 0.1 mg of IFN -y did not significantly (P> 0.05) 
affect the ability of PMN s to kill B. abortus at any of the time intervals tested. 
Neutrophils from animals treated with 0.5 mg of IFN -y exhibited a statistically 
significant (P < 0.025) enhancement of brucellacidal activity 24 h following 
treatment when compared with PMNs from control animals. Phagocytes from 
animals treated with 0.5 mg of IFN-y were capable of killing 0.84::!::0.lllog10 
of exposed B. abortus within 90 min while PMNs from control animals killed 
0.54::!::: 0.08 log10 of the bacteria. The greatest difference in killing potential 
between PMNs from control and IFN-y-treated animals occurred within the 
first 30 min following the addition of bacteria. Neutrophils from control ani-
mals killed 0.41::!::: 0.04 log10 of B. abortus during the first 30 min of exposure, 
while PMN s from animals treated with 0.5 mg of IFN -y killed 0. 71 ::!::: 0.04 log10 
of the organisms in the same amount of time. There were no significant 
(P> 0.05) differences in the killing potentials of PMNs from control or IFN-
y-treated animals at 48 or 72 h post-treatment. 
DISCUSSION 
Activation of PMN s either in vitro or in vivo with recombinant bovine IFN-
y resulted in the activation of these cells as evidenced by the markedly sup-
pressed ability of neutrophils to migrate under agarose as reported previously 
(Steinbeck et al., 1986). 
Both resting and opsonized zymosan-stimulated PMNs produced greater 
amounts of 0 2 - in the presence of IFN -y. These results differ from those re-
ported previously in which IFN-y-activation of PMNs failed to increase pro-
duction of 0 2 - (Steinbeck et al., 1986). However, a bovine lymphokine prep-
a.ration containing interferon activity has previously been shown to enhance 
0 2 - production by opsonized zymosan-stimulated bovine neutrophils (Lukacs 
et al., 1985). The reasons for this discrepancy are unclear, but it is possible 
that variations in experimental protocols, INF -y preparations or differences 
between animals might be responsible. 
Brucella abortus survival within neutrophils has been associated with the 
expression of PMN suppressive purines on the bacterial surface which inhibit 
MPO-H20 2-halide activity (Canning et al., 1986). Results of the experiments 
designed to determine the effects of recombinant IFN -y on the MPO-H 20 2 -
halide activity of PMN s indicated that in vitro activation of PMN s with IFN-
y significantly enhanced the iodination responses of neutrophils when they 
were stimulated with concentrations of opsonized zymosan which produced 
less than maximal iodination. When a concentration of opsonized zymosan 
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was used which stimulated maximal iodination activity (10 mg/ml), the IFN-
y treatment did not enhance iodination in either the present or a previous study 
(Steinbeck et al., 1986). The iodination assay used in the current experimen-
tation involved stimulation of iodination responses with a dose of opsonized 
zymosan which stimulated approximately 80% of maximal iodination activity. 
This level of stimulation provided the optimal sensitivity for the detection of 
enhanced iodination activity due to IFN-y-induced PMN activation while 
maintaining the sensitivity needed for detecting suppression by either purines 
or live B. abortus. 
Results of the iodination experiments involving in vivo activation of PMN s 
indicated IFN -y significantly increased the iodination responses of either rest-
ing or opsonized zymosan-stimulated neutrophils within the first 24 h follow-
ing treatment (Fig. 5 ). 
Both in vitro and in vivo activation of PMNs with IFN-y resulted in an 
improved iodination response by phagocytes in the presence of GMP and ad-
enine or B. abortus. Neutrophils from animals treated with either the high or 
low dose of IFN-y and assayed after 24 h produced similar levels of iodination 
activity in the presence of GMP and adenine or B. abortus as control prepa-
rations of PMNs from non-treated animals. The magnitude of the iodination-
enhancing effect of IFN-y was directly proportional to the dose administered. 
The duration of the enhancement of iodination by IFN -y activation of PMN s 
was short lived (less than 48 h). 
Bactericidal assays involving normal PMNs indicated B. abortus was capa-
ble of resisting killing by PMNs. Although a substantial number of opsonized 
B. abortus were killed by neutrophils, a residual population (approximately 
35-40% of the original inoculum) of B. abortus survived exposure to PMN s for 
90-120 min. 
If suppression of the MPO-H 20 2 - halide activity of PMN splays a significant 
role in the survival of B. abortus, it seems plausible that reversal of this inhi-
bition would result in an increase in the brucellacidal activity of PMNs. Re-
sults of the studies to determine effects of IFN -yon the brucellacidal activity 
of PMNs indicated pretreatment of PMNs with IFN-y for 2 h resulted in a 
modest, but statistically significant (P < 0.01), enhancement of the ability of 
PMN s to kill B. abortus. The enhancement of killing was most notable during 
the first 30 min following the addition of the bacteria. During this time inter-
val, the IFN -y-treated PMN skilled approximately twice the amount of B. abor-
tus as did the normal PMNs. The differences in the killing potential between 
normal and activated PMNs decreased at 60 and 120 min post-exposure. 
Recombinant IFN -y treatment of animals also resulted in slightly improved 
brucellacidal activity ofPMNs in a dose- and dependent manner. The low dose 
of IFN-y did not measurably affect the bactericidal potential of PMNs. Neu-
trophils from animals treated with 0.5 mg of IFN-y exhibited statistically sig-
nificant (P < 0.025) increases in their ability to kill B. abortus within 24 h of 
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treatment. The magnitude of the enhancement of killing was greatest during 
the first 30 min following the addition of the PMNs to the reaction mixture, 
similar to the in vitro activation studies. Neutrophils from animals treated 
with 0.5 mg of IFN-y killed approximately 25% more bacteria during this time 
interval than did PMNs from control animals. The differences in killing po-
tential between PMNs from control or IFN-y-treated animals decreased to 
approximately 10% at 90 min post-exposure. These results suggest that IFN-
y-activation of PMNs may change the kinetics of the antibacterial activity of 
neutrophils by increasing the early antibacterial capacity of the phagocyte, 
resulting in an overall enhanced bactericidal potential. Neither the low nor the 
high dose of IFN -y enhanced the brucellacidal activity of PMN s beyond 24 h 
post-treatment. 
The results of these studies suggest that activation of PMNs with INF -y 
partially enhances both oxygen radical production and iodination responses, 
resulting in a statistically significant increase in their ability to kill B. abortus 
when compared with normal neutrophils. However, the small magnitude of the 
difference and survival of a significant number of bacteria at 90-120 min post-
exposure forces one to question the biological significance of the increased 
killing potential. 
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